User profiles for S M Gabe
Simon GabeConsultant Gastroenterologist, St Mark's Hospital and Imperial College Verified email at nhs.net Cited by 6092 |
Nutrition and management of enterocutaneous fistula
DAJ Lloyd, SM Gabe, ACJ Windsor - Journal of British Surgery, 2006 - academic.oup.com
Background The management of enterocutaneous fistula is challenging, with significant
associated morbidity and mortality. This article reviews treatment, with emphasis on the …
associated morbidity and mortality. This article reviews treatment, with emphasis on the …
Mortality after acute primary mesenteric infarction: a systematic review and meta‐analysis of observational studies
Aim The primary aim of this study was to determine whether the in‐hospital mortality for acute
mesenteric infarction has reduced in the last decade. The secondary aim was to determine …
mesenteric infarction has reduced in the last decade. The secondary aim was to determine …
Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds
…, S Shurey, JA Roether, A Forbes, LL Hench, SM Gabe - Biomaterials, 2004 - Elsevier
Sufficient neovascularization of neotissue is currently a limiting factor for the engineering of
large tissue constructs. 45S5 Bioglass ® has been investigated extensively in bone tissue …
large tissue constructs. 45S5 Bioglass ® has been investigated extensively in bone tissue …
An 11-year experience of enterocutaneous fistula
…, J Mawdsley, W Lim, SM Gabe… - Journal of British …, 2004 - academic.oup.com
Background Enterocutaneous fistula has traditionally been associated with substantial
morbidity and mortality, related to fluid, electrolyte and metabolic disturbance, sepsis and …
morbidity and mortality, related to fluid, electrolyte and metabolic disturbance, sepsis and …
Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome
…, SJD O'keefe, K Fujioka, SM Gabe… - Clinical and …, 2016 - journals.lww.com
… Schwartz, Lauren K 1 ; O'Keefe, Stephen JD 2 ; Fujioka, Ken 3 ; Gabe, Simon M 4 ; Lamprecht,
… SM Gabe and U.-F. Pape were advisory board members and study investigators for NPS …
… SM Gabe and U.-F. Pape were advisory board members and study investigators for NPS …
Survival and dependence on home parenteral nutrition: experience over a 25‐year period in a UK referral centre
…, P Bassett, A Forbes, SM Gabe - Alimentary …, 2006 - Wiley Online Library
Background Home parenteral nutrition (HPN) is the standard treatment for severe intestinal
failure in the United Kingdom. Aim To review long‐term survival and ongoing HPN …
failure in the United Kingdom. Aim To review long‐term survival and ongoing HPN …
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans
SM Gabe, I Bjarnason, Z Tolou–Ghamari, JM Tredger… - Gastroenterology, 1998 - Elsevier
Background & Aims: The maintenance of the intestinal mucosal barrier may be energy
dependent. Tacrolimus is a potent immunosuppressive drug that decreases mitochondrial …
dependent. Tacrolimus is a potent immunosuppressive drug that decreases mitochondrial …
Managing liver dysfunction in parenteral nutrition: BAPEN Symposium 4 on 'Managing complications in long-term parenteral nutrition'
DAJ Lloyd, SM Gabe - Proceedings of the Nutrition Society, 2007 - cambridge.org
Parenteral nutrition is life saving in patients with intestinal failure but liver dysfunction is
commonly encountered, especially in neonates. Although abnormal liver function tests …
commonly encountered, especially in neonates. Although abnormal liver function tests …
Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients
BACKGROUND & AIMS: Refeedinghypophosphataemia (RH) can result in sudden death.
This study aimed to compare the incidence of RH between patients fed enterally and those fed …
This study aimed to compare the incidence of RH between patients fed enterally and those fed …
[HTML][HTML] Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure
PB Jeppesen, SM Gabe, DL Seidner, HM Lee, C Olivier - Gastroenterology, 2018 - Elsevier
Background & Aims Clinical studies showed teduglutide to increase urine production and
reduce need for parenteral support volume in patients with short bowel syndrome (SBS) with …
reduce need for parenteral support volume in patients with short bowel syndrome (SBS) with …